Stock Earnings

Question 1

What are Chemomab Therapeutics Ltd's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Chemomab Therapeutics Ltd has a total asset of $16, Net loss of $-13

Question 2

What are the key financial ratios for CMMB?

Accepted Answer

Chemomab Therapeutics Ltd's Current ratio is 5.33, has a Net margin is 0, sales per share of $0.

Question 3

How is Chemomab Therapeutics Ltd's revenue broken down by segment or geography?

Accepted Answer

Currently Chemomab Therapeutics Ltd data is not available.

Question 4

Is Chemomab Therapeutics Ltd profitable?

Accepted Answer

no, according to the latest financial statements, Chemomab Therapeutics Ltd has a net loss of $-13

Question 5

Does Chemomab Therapeutics Ltd have any liabilities?

Accepted Answer

yes, Chemomab Therapeutics Ltd has liability of 3

Question 6

How many outstanding shares for Chemomab Therapeutics Ltd?

Accepted Answer

Chemomab Therapeutics Ltd has a total outstanding shares of 94.28

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	--	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	3	2	--	--
Gross Profit	--	--	--	-2	--	--
Selling, General & Admin	3	3	7	11	6	7
Research & Development	9	11	18	13	6	3
Operating Expenses	12	14	22	25	12	10
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-11	-13	-24	-28	-12	-11
Income Tax Expense	--	0	0	0	--	--
Net Income	-11	-13	-24	-27	-12	-11
Net Income Growth	-21%	-46%	-11%	125%	9%	-59%
Shares Outstanding (Diluted)	115.87	89.76	58.74	56.89	3.24	0.57
Shares Change (YoY)	62%	53%	3%	1,655%	459%	8%
EPS (Diluted)	-0.1	-0.15	-0.41	-0.48	-3.84	-20.02
EPS Growth	-45%	-62%	-14%	-88%	-81%	-60%
Free Cash Flow	-14	-15	-23	-20	-12	-5
Free Cash Flow Per Share	-0.12	-0.16	-0.39	-0.35	-3.7	-8.62
Gross Margin	--	--	--	0%	--	--
Operating Margin	0%	0%	--	0%	0%	0%
Profit Margin	0%	0%	--	0%	0%	0%
Free Cash Flow Margin	0%	0%	--	0%	0%	0%
EBITDA	-12	-14	-25	-28	-12	-10
EBITDA Margin	0%	0%	--	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-12	-14	-25	-28	-12	-10
EBIT Margin	0%	0%	--	0%	0%	0%
Effective Tax Rate	--	0%	0%	0%	--	--

Chemomab Therapeutics Ltd (CMMB) Price